Sysmex Corporation (SSMXF)

Market Cap	5.57B -46.8%
Revenue (ttm)	3.14B -1.7%
Net Income	222.99M -33.9%
EPS	0.36 -33.9%
Shares Out	n/a
PE Ratio	24.99
Forward PE	n/a
Dividend	0.25 (2.79%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	8.85
Previous Close	8.85
Day's Range	8.85 - 8.85
52-Week Range	7.97 - 17.52
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,533
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In fiscal year 2026, Sysmex's revenue was 500.01 billion, a decrease of -1.70% compared to the previous year's 508.64 billion. Earnings were 35.46 billion, a decrease of -33.93%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error